H. Lundbeck A/S
H. Lundbeck A/S (Denmark) has DMF or CEP filings on record for 1 active ingredient. 2 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “H. Lundbeck A/S: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/h-lundbeck-a-s
Overview
Lundbeck LLC is the U.S. subsidiary of H. Lundbeck A/S, a global pharmaceutical company specializing in brain diseases. The company focuses on developing innovative therapies for disorders such as depression, Alzheimer's disease, and Parkinson's disease.
Core services & business areas
Therapeutic areas
Active ingredients with DMF or CEP filings
Substances for which H. Lundbeck A/S holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
FDA compliance signals
2 FDA enforcement records linked to this company.
- 4832018-04-27
Quality control unit review of records
- 4832018-04-27
Procedures not in writing, fully followed
Is this H. Lundbeck A/S?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.